ETFs
S
MCRB
Seres Therapeutics Inc
8.76
-0.09-1.02%After Hours: 9.01 +0.25 +2.85%18:46 04/08 EDT
OPEN/PREV CLOSE8.62/8.61
TODAY RANGE8.48-8.86
VOL42.44K
MARKET CAP84.74M
52 WEEK RANGE6.53-29.98
AVG VOL (3M)65.63K
% TURNOVER0.44%
TURNOVER--
P/E (TTM)13.77
% RANGE4.43%
EPS(TTM)0.6422
P/E(FORWARD)-1.0741
P/B1.911
BVPS4.627
DIVIDEND--
P/S107.02
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP74.61M
SHARES OUTSTANDING9.59M
NEXT EARNINGS05/05-05/11
FREE FLOAT8.44M
LOT SIZE1
EX-DATE04/22/2025
News
Press Releases
Financial Reports
Profile
TipRanks·03/16 21:03
Seres Therapeutics Sets 2026 Annual Shareholder Meeting Date
Dow Jones·03/13 18:33
Seres Therapeutics Is Maintained at Buy by Canaccord Genuity
Dow Jones·03/13 18:33
Seres Therapeutics Price Target Maintained With a $22.00/Share by Canaccord Genuity
TipRanks·03/13 11:59
Canaccord Genuity Remains a Buy on Seres Therapeutics (MCRB)
Seeking Alpha·03/12 19:38
Seres Therapeutics GAAP EPS of $0.64, revenue of $0.78M
TipRanks·03/12 12:08
Seres Therapeutics Reports 2025 Results, Highlights Refocused Pipeline
TipRanks·03/12 11:15
Seres Therapeutics reports FY25 EPS 64c
Dow Jones·03/12 11:15
*Seres Therapeutics 2025 EPS 64c >MCRB
Dow Jones·03/12 11:15
*Seres Therapeutics 2025 Rev $789,000 >MCRB
Reuters·03/12 11:14
Seres Therapeutics posts 2025 profit as expenses fall
Benzinga·03/12 11:11
Earnings Scheduled For March 12, 2026
Reuters·03/12 11:00
BRIEF-Seres Therapeutics FY EPS USD 0.64
Same Industry
Name/Symbol
Change%
Price